Introduction Myasthenia gravis (MG) is an autoimmune disease, for which the risk of
exacerbation after vaccines is debated. The aim of this study is to review the available …

Introduction Viral infection such as coronavirus disease 2019 (COVID-19) can exacerbate
and aggravate neurological disorders due to autoimmune etiology like myasthenia gravis …

Background and aims. Patients with Myasthenia gravis (MG) are considered vulnerable as
they may present with respiratory muscle weakness and because they are on …

COVID-19 affects the respiratory parenchyma and may potentially contribute to the tendency
of myasthenia gravis (MG) patients to develop respiratory failure. It is, therefore, important to …

Background Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular
junction that can be exacerbated by many viral infections, including COVID-19. The …

Objective Recent studies suggest that the clinical course and outcomes of patients with
coronavirus disease 2019 (COVID-19) and myasthenia gravis (MG) are highly variable. We …

In December 2019, the novel coronavirus disease (COVID-19) due to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection broke. With the gradual …

Abstract Introduction/Aims Coronavirus disease‐2019 (COVID‐19) may have a more severe
course in patients with myasthenia gravis (MG). We aimed to assess severity of the infection …

SARS-CoV-2 virus infection is the cause of the coronavirus disease 2019 (COVID-19), which
is still spreading over the world. The manifestation of this disease can range from mild to …

Introduction Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular
junction which is typically presented with muscle weakness and excessive fatigability …